שימוש בנוגדנים קושרי il-1b לטיפול בצהבת אלכוהולית
- 专利权人:
- NOVARTIS AG
- 发明人:
- 申请号：
- IL27320420
- 公开号：
- IL273204D0
- 申请日:
- 2020.03.10
- 申请国别(地区):
- IL
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to a method for treating or alleviating the symptoms of alcoholic hepatitis in a subject, comprising administering gevokizumab or 2-5 mg of canakinumab per kg of body weight to a subject in need thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of il-1b binding antibodies for the treatment of alcoholic hepatitis
- USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS
- UTILISATION D'ANTICORPS SE LIANT A IL-1B POUR LE TRAITEMENT DE L'HEPATITE ALCOOLIQUE
- Use of IL-1B binding antibodies for the treatment of alcoholic hepatitis
- Treatment of alcoholic hepatitis with anti-il-1b antibody
